Nyxoah SA ROE 2021-2025 | NYXH

Current and historical return on equity (ROE) values for Nyxoah SA (NYXH) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Nyxoah SA ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2025-03-31 $-0.08B $0.10B -64.52%
2024-12-31 $-0.06B $0.12B -55.41%
2024-09-30 $-0.06B $0.12B -52.13%
2024-06-30 $-0.05B $0.13B -41.96%
2024-03-31 $-0.05B $0.10B -42.25%
2023-12-31 $-0.05B $0.11B -38.84%
2023-09-30 $-0.05B $0.12B -38.81%
2023-06-30 $-0.05B $0.13B -36.08%
2023-03-31 $-0.04B $0.13B -28.04%
2022-12-31 $-0.03B $0.13B -23.24%
2022-03-31 $-0.02B $0.16B -16.09%
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.274B $0.005B
Nyxoah SA is a medical technology company. It focused on the development and commercialization of solutions to treat Obstructive Sleep Apnea. Nyxoah SA is based in Belgium.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $38.234B 52.81
Hims & Hers Health (HIMS) United States $12.982B 134.88
Tempus AI (TEM) United States $10.012B 0.00
IRhythm Technologies (IRTC) United States $4.465B 0.00
Inspire Medical Systems (INSP) United States $4.309B 67.32
Privia Health (PRVA) United States $2.902B 198.33
Enovis (ENOV) United States $1.848B 10.30
Clover Health Investments (CLOV) United States $1.791B 0.00
Schrodinger (SDGR) United States $1.498B 0.00
Phreesia (PHR) United States $1.456B 0.00
Omnicell (OMCL) United States $1.281B 22.59
Azenta (AZTA) United States $1.258B 58.47
10x Genomics (TXG) United States $1.024B 0.00
Fulgent Genetics (FLGT) United States $0.618B 0.00
Butterfly Network (BFLY) United States $0.534B 0.00
Talkspace (TALK) United States $0.486B 145.25
Veradigm (MDRX) United States $0.476B 0.00
Claritev (CTEV) United States $0.473B 0.00
Standard BioTools (LAB) United States $0.395B 0.00
TruBridge (TBRG) United States $0.363B 805.00
Health Catalyst (HCAT) United States $0.260B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.195B 0.00
EUDA Health Holdings (EUDA) Singapore $0.141B 0.00
Pulmonx (LUNG) United States $0.126B 0.00
American Well (AMWL) United States $0.116B 0.00
MDxHealth SA (MDXH) Belgium $0.099B 0.00
CareCloud (CCLD) United States $0.086B 3.27
111 (YI) China $0.067B 0.00
Outset Medical (OM) United States $0.067B 0.00
P3 Health Partners (PIII) United States $0.056B 0.00
HeartBeam (BEAT) United States $0.053B 0.00
Retrieve Medical Holdings (RMHI) United States $0.051B 0.00
Zepp Health (ZEPP) Netherlands $0.038B 0.00
Zhongchao (ZCMD) China $0.033B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.022B 0.00
Bullfrog AI Holdings (BFRG) United States $0.017B 0.00
Precipio (PRPO) United States $0.015B 0.00
MSP Recovery (MSPR) United States $0.012B 0.00
Strata Skin Sciences (SSKN) United States $0.010B 0.00
Predictive Oncology (POAI) United States $0.010B 0.00
Streamline Health Solutions (STRM) United States $0.009B 0.00
Movano (MOVE) United States $0.004B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.004B 0.00
Healthcare Triangle (HCTI) United States $0.000B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00